title: Analysis of urinary human chorionic gonadotrophin concentrations in normal and failing pregnancies using longitudinal, Cox proportional hazards and two-stage modelling.
abstract: Background Human chorionic gonadotrophin is a marker of early pregnancy. This study sought to determine the possibility of being able to distinguish between healthy and failing pregnancies by utilizing patient-associated risk factors and daily urinary human chorionic gonadotrophin concentrations. Methods Data were from a study that collected daily early morning urine samples from women trying to conceive (n = 1505); 250 of whom became pregnant. Data from 129 women who became pregnant (including 44 miscarriages) were included in these analyses. A longitudinal model was used to profile human chorionic gonadotrophin, a Cox proportional hazards model to assess demographic/menstrual history data on the time to failed pregnancy, and a two-stage model to combine these two models. Results The profile for log human chorionic gonadotrophin concentrations in women suffering miscarriage differs to that of viable pregnancies; rate of human chorionic gonadotrophin rise is slower in those suffering a biochemical loss (loss before six weeks, recognized by a rise and fall of human chorionic gonadotrophin) and tends to plateau at a lower log human chorionic gonadotrophin in women suffering an early miscarriage (loss six weeks or later), compared with viable pregnancies. Maternal age, longest cycle length and time from luteinizing hormone surge to human chorionic gonadotrophin reaching 25 mIU/mL were found to be significantly associated with miscarriage risk. The two-stage model found that for an increase of one day in the time from luteinizing hormone surge to human chorionic gonadotrophin reaching 25 mIU/mL, there is a 30% increase in miscarriage risk (hazard ratio: 1.30; 95% confidence interval: 1.04, 1.62). Conclusion Rise of human chorionic gonadotrophin in early pregnancy could be useful to predict pregnancy viability. Daily tracking of urinary human chorionic gonadotrophin may enable early identification of some pregnancies at risk of miscarriage.
authors.affiliation: 1 SPD Development Co., Ltd, Bedford, UK.
authors.forename: Lorrae
authors.initials: L
authors.lastname: Marriott
authors.affiliation: 2 Jacobi Medical Center, Department Obstetrics and Gynecology, Bronx, NY, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Zinaman
authors.affiliation: 3 Department of Health Sciences, University of Leicester, Leicester, UK.
authors.forename: Keith R
authors.initials: KR
authors.lastname: Abrams
authors.affiliation: 3 Department of Health Sciences, University of Leicester, Leicester, UK.|4 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Crowther
authors.affiliation: 5 SPD Development Co., Ltd, Bedford, UK.
authors.forename: Sarah
authors.initials: S
authors.lastname: Johnson
mesh_terms: D000022:Abortion, Spontaneous / Q000652:urine*; D000293:Adolescent; D000328:Adult; D006063:Chorionic Gonadotropin / Q000652:urine*; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D015233:Models, Statistical; D011247:Pregnancy; D016016:Proportional Hazards Models; D018570:Risk Assessment; D016482:Urinalysis; D055815:Young Adult
chemical_list: D006063:Chorionic Gonadotropin
keywords: Clinical studies; pregnancy